New report adds to growing evidence of iNKT cell therapy’s potential in solid tumors. NEW YORK, July 11, 2025 (GLOBE NEWSWIRE ...

Shares of MiNK Therapeutics, Inc. (INKT) skyrocketed on Friday following the publication of a case from its clinical trial ...

Testicular cancer is not very common, but it deserves careful consideration because it can act rapidly in nonseminomatous germ cell tumours, which are more virulent than seminomas. Testicular cancer ...

Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...

Experimental treatment could offer a safer, cheaper alternative to CAR-T-cell therapies for disorders such as lupus.

In the realm of cancer biology, the intersection of aging and cancer presents unique challenges, characterized by tumor ...